Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
IMGN > SEC Filings for IMGN > Form 8-K on 27-Aug-2013All Recent SEC Filings

Show all filings for IMMUNOGEN INC

Form 8-K for IMMUNOGEN INC


27-Aug-2013

Change in Directors or Principal Officers, Financial Statements and Exhibits


ITEM 5.02 - DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

(a) Not applicable.

(b) On August 27, 2013, ImmunoGen, Inc. (the "Company") announced that Gregory D. Perry, Executive Vice President and Chief Financial Officer, has provided notice of his intention to resign from the Company effective as of September 13, 2013. In connection with Mr. Perry's resignation, he and the Company will be entering into a Transition and Separation Agreement which provides, among other things, that the existing employment agreement between the Company and Mr. Perry will be terminated, and the Company will provide Mr. Perry a salary continuation benefit equal to twelve months of his current base salary.

(c) Effective immediately following Mr. Perry's departure, Daniel M. Junius, the Company's President and Chief Executive Officer, will become acting chief financial officer (and principal financial officer and principal accounting officer) while a search is undertaken to hire Mr. Perry's replacement. There have been no changes to Mr. Junius' current arrangements with the Company as a result of these additional responsibilities.

(d) Not applicable.

(e) See paragraph (b) above.

(f) Not applicable.



ITEM 9.01. - FINANCIAL STATEMENTS AND EXHIBITS

(d) The following exhibit is being furnished herewith:

Exhibit No. Exhibit

99.1 Press Release of ImmunoGen, Inc. dated August 27, 2013


  Add IMGN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for IMGN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.